ArticleBMC infectious diseases2014
Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis.
Article in BMC infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.
- A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis.International urology and nephrology · 2022Pooled it
- Development and Internal Validation of the AP-Score for Predicting Percutaneous Nephrostomy Use in Acute Obstructive Pyelonephritis.Journal of clinical medicine · 2026Article
- Minimally invasive treatment of emphysematous pyelonephritis in diabetic patients: a comparative study.BMC urology · 2026Article
- Emergency nephrectomy for fulminant emphysematous pyelonephritis mimicking gastroenteritis: A case report.The Journal of international medical research · 2026Article
- Medical management of emphysematous pyelonephritis: a case report.Annals of medicine and surgery (2012) · 2025Article
- Article
- Emphysematous pyelonephritis caused by Raoultella ornithinolytica: a case report.BMC nephrology · 2024Article
- Scoring System to Personalize Management of Emphysematous Pyelonephritis.Urology research & practice · 2024Article
- A novel mortality risk score for emphysematous pyelonephritis: A multicenter study of the Global Research in the Emphysematous Pyelonephritis group.Current urology · 2024Article
- Report on the diagnosis and treatment of 3 cases of emphysematous pyelonephritis with two different outcomes.Frontiers in medicine · 2024Article
- Severe emphysematous pyelonephritis as a complication of klebsiella pneumonia and uncontrolled diabetes mellitus.BJR case reports · 2023Article
- The Importance of Early Imaging in Acute Pyelonephritis: A Case Report of Emphysematous Pyelonephritis.Cureus · 2023Article
- Predictors of mortality and nephrectomy in emphysematous pyelonephritis: a tertiary care centre study.Annals of the Royal College of Surgeons of England · 2023Article
- Article
- Successful nephrectomy after a failure of non-surgical treatment in emphysematous pyelonephritis: A case report.Heliyon · 2022Article
- Culture-Negative Emphysematous Pyelonephritis as a Complication of Uncontrolled Diabetes Mellitus: A Case Report.Cureus · 2022Article
- Predictive factors for failure of conservative management in patients with emphysematous pyelonephritis.Annals of medicine and surgery (2012) · 2022Article
- Evolving case of emphysematous pyelonephritis in a second renal allograft.Urology case reports · 2021Article
- Hyperglycaemic crisis secondary to emphysematous pyelonephritis.BMJ case reports · 2021Article
- Point-of-care ultrasound for the early diagnosis of emphysematous pyelonephritis: A case report and literature review.World journal of clinical cases · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEmphysematous pyelonephritis (EPN) is a severe necrotizing infection of the renal parenchyma and perirenal tissues that is caused by gas-producing bacterial pathogens. Percutaneous drainage is now the gold standard of definitive management. The aim of this study is to analyze the predictors associated with failure of conservative treatment among patients with EPN and offer the recommendation of appropriate empirical antibiotic regimen.
methodsFrom January 2001 to December 2013, 44 consecutive patients were diagnosed with EPN. The demographic characteristics, clinical presentations, management strategies, and final outcomes were analyzed retrospectively.
resultsThe overall survival rate was 88.6% (39/44). Need for emergency hemodialysis, shock on initial presentation, altered mental status, severe hypoalbuminemia, inappropriate empirical antibiotic treatment and polymicrobial infections were significantly more common in the patients who died compared with the survivors. The overall failure rate of conservative treatment was 32.6% (14/43). Severe hypoalbuminemia (p = 0.003), need for emergency hemodialysis (p = 0.03), and polymicrobial infections (p = 0.04) were significantly associated with failure of conservative treatment. Severe hypoalbuminemia was independently associated with conservative management failure (p = 0.02). Even in the patients treated with percutaneous drainage plus effective antibiotics, failure was still associated with severe hypoalbuminemia (p = 0.01). According to the in vitro susceptibility data, third-generation cephalosporins is recommended as the empirical antibiotic regimen.
conclusionsBoth appropriate empirical antibiotic and percutaneous drainage were essential for patients with EPN. Patients with severe hypoalbuminemia had a higher risk of conservative treatment failure, and additional management may be required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.